Vaccine and Infectious Disease Division

A Multidisciplinary Approach to Reducing the Burden of Infectious Disease

The Vaccine and Infectious Disease Division (VIDD) is a recognized leader in translational and “bench-to-bedside” science. VIDD integrates the expertise and creativity of scientists in basic, translational and clinical research to prevent, treat and cure infectious diseases, including known and emerging infections of major global health importance such as COVID-19, HIV and cancer-related infectious diseases.

Applying an innovative multidisciplinary approach, our division houses three formal research programs that systematically pursue explicit goals aimed at eliminating the burden of death and disease from infection. These programs include Biostatistics, Bioinformatics and Epidemiology; Immunology and Vaccine Development; and Infectious Disease Sciences

VIDD also houses major collaborative research networks including the COVID-19 Prevention Network (CoVPN), HIV Vaccine Trials Network (HVTN) and the HIV Prevention Trials Network (HPTN), which engage researchers globally in the development of preventive vaccines for COVID-19 and HIV.

Within these programs and networks, VIDD’s scientists relentlessly work to develop innovative approaches to preventing and treating HIV, coronavirus and other infectious diseases, improve treatment of serious infections among immunocompromised patients and create novel techniques to reduce the impact of infectious diseases worldwide.

Lund / Prlic lab
Faculty & Labs

Creating Better Outcomes

Our multidisciplinary faculty perform laboratory and clinical research as well as employ advanced computational methods to gain insight into how to better predict, prevent and treat infectious diseases.

Cell Processing
Research Programs

A Global Approach

Division researchers study multiple infectious diseases, such as COVID-19, HIV, malaria and influenza. Our goal is to develop vaccines and therapies that reduce their impact.


Our Global Reach

VIDD’s collaborative research initiatives span the globe and include laboratory, clinical and field sites in North and South America, Africa, Asia and Europe. 

Participate in a Clinical Trial Near You

Latest Vaccine and Infectious Disease News

What Hutch coronavirus experts are saying about omicron Some answers, but many questions, about highly mutated new variant of COVID-19 virus January 21, 2022
Latest Fred Hutch research on COVID-19 How Hutch scientists have been tackling coronavirus in lab and clinic January 4, 2022
Hopes and predictions for 2022 Hutch researchers look ahead to an increase in cancer screening, improved vaccines and greater trust in science December 21, 2021
Highlights of Fred Hutch science in 2021 From COVID-19 to cancer, Hutch scientists pursued new ideas to save lives December 20, 2021
Last Modified, September 21, 2021